Cargando…
A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease
To analyze outcomes following major lower extremity amputations (mLEAs) for peripheral arterial obstructive disease, gangrene, infected non-healing wound and to create a risk prediction scoring system for 30-day mortality. In this single-center, retrospective, observational cohort study. All patient...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500910/ https://www.ncbi.nlm.nih.gov/pubmed/34120323 http://dx.doi.org/10.1007/s13304-021-01085-5 |
_version_ | 1784580546271117312 |
---|---|
author | Franchin, Marco Palermo, Vincenzo Iannuzzi, Carlo Rivolta, Nicola Mozzetta, Gaddiel Tozzi, Matteo Bush, Ruth L. Piffaretti, Gabriele |
author_facet | Franchin, Marco Palermo, Vincenzo Iannuzzi, Carlo Rivolta, Nicola Mozzetta, Gaddiel Tozzi, Matteo Bush, Ruth L. Piffaretti, Gabriele |
author_sort | Franchin, Marco |
collection | PubMed |
description | To analyze outcomes following major lower extremity amputations (mLEAs) for peripheral arterial obstructive disease, gangrene, infected non-healing wound and to create a risk prediction scoring system for 30-day mortality. In this single-center, retrospective, observational cohort study. All patients treated with above-the-knee amputation (AKA) or below-the-knee amputation (BKA) between January 1st, 2010 and June 30th, 2018 were identified. The primary outcome of interest was early (≤ 30 days) mortality. Secondary outcomes were postoperative complications and freedom from amputation stump revision/failure. We identified 310 (77.7%) mLEAs performed on 286 patients. There were 188 (65.7%) men and 98 (34.3%) women with a median age of 79 years (IQR, 69–83 years). We performed 257 (82.9%) AKA and 53 (17.1%) BKA. There were 49 (15.8%) early deaths, which did not differ among the age quartiles of this cohort (15.4% vs. 14.3% vs. 15.4% vs. 19.5%, P = 0.826). Binary logistic regression analysis identified age > 80 years (OR 2.24, 95% CI 1.17–4.31; P = 0.015), chronic obstructive pulmonary disease (OR 2.12, 95% CI 1.11–4.06; P = 0.023), and hemodialysis (OR 2.52, 95% CI 1.15–5.52; P = 0.021) to be associated with early mortality. The final score (range 0–10) identified two subgroups with different mortality at 30 days: lower-risk (score < 4, 10.8%), and higher-risk (score ≥ 4: 28.7%; OR 3.2, 95% CI 1.63–6.32; P < 0.001). In our experience, mLEAs still have a 14% mortality rate over the years. Our lower-risk group (score < 4) is characterized by a lower rate of perioperative death and longer survival. GRAPHIC ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8500910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-85009102021-10-22 A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease Franchin, Marco Palermo, Vincenzo Iannuzzi, Carlo Rivolta, Nicola Mozzetta, Gaddiel Tozzi, Matteo Bush, Ruth L. Piffaretti, Gabriele Updates Surg Original Article To analyze outcomes following major lower extremity amputations (mLEAs) for peripheral arterial obstructive disease, gangrene, infected non-healing wound and to create a risk prediction scoring system for 30-day mortality. In this single-center, retrospective, observational cohort study. All patients treated with above-the-knee amputation (AKA) or below-the-knee amputation (BKA) between January 1st, 2010 and June 30th, 2018 were identified. The primary outcome of interest was early (≤ 30 days) mortality. Secondary outcomes were postoperative complications and freedom from amputation stump revision/failure. We identified 310 (77.7%) mLEAs performed on 286 patients. There were 188 (65.7%) men and 98 (34.3%) women with a median age of 79 years (IQR, 69–83 years). We performed 257 (82.9%) AKA and 53 (17.1%) BKA. There were 49 (15.8%) early deaths, which did not differ among the age quartiles of this cohort (15.4% vs. 14.3% vs. 15.4% vs. 19.5%, P = 0.826). Binary logistic regression analysis identified age > 80 years (OR 2.24, 95% CI 1.17–4.31; P = 0.015), chronic obstructive pulmonary disease (OR 2.12, 95% CI 1.11–4.06; P = 0.023), and hemodialysis (OR 2.52, 95% CI 1.15–5.52; P = 0.021) to be associated with early mortality. The final score (range 0–10) identified two subgroups with different mortality at 30 days: lower-risk (score < 4, 10.8%), and higher-risk (score ≥ 4: 28.7%; OR 3.2, 95% CI 1.63–6.32; P < 0.001). In our experience, mLEAs still have a 14% mortality rate over the years. Our lower-risk group (score < 4) is characterized by a lower rate of perioperative death and longer survival. GRAPHIC ABSTRACT: [Image: see text] Springer International Publishing 2021-06-13 2021 /pmc/articles/PMC8500910/ /pubmed/34120323 http://dx.doi.org/10.1007/s13304-021-01085-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Franchin, Marco Palermo, Vincenzo Iannuzzi, Carlo Rivolta, Nicola Mozzetta, Gaddiel Tozzi, Matteo Bush, Ruth L. Piffaretti, Gabriele A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease |
title | A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease |
title_full | A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease |
title_fullStr | A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease |
title_full_unstemmed | A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease |
title_short | A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease |
title_sort | predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500910/ https://www.ncbi.nlm.nih.gov/pubmed/34120323 http://dx.doi.org/10.1007/s13304-021-01085-5 |
work_keys_str_mv | AT franchinmarco apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT palermovincenzo apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT iannuzzicarlo apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT rivoltanicola apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT mozzettagaddiel apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT tozzimatteo apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT bushruthl apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT piffarettigabriele apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT franchinmarco predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT palermovincenzo predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT iannuzzicarlo predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT rivoltanicola predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT mozzettagaddiel predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT tozzimatteo predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT bushruthl predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease AT piffarettigabriele predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease |